NCT05495906View on ClinicalTrials.gov

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

PHASE4RecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

January 31, 2028

Conditions
HPVHuman Papilloma VirusHuman Immunodeficiency Virus
Interventions
BIOLOGICAL

Nonavalent HPV vaccine

Routine dosing form and dosage

Trial Locations (10)

V3T 0G9

NOT_YET_RECRUITING

Positive Health Services - Fraser Health, Surrey

V6H 2N1

RECRUITING

University of British Columbia, Vancouver

R3A1R9

NOT_YET_RECRUITING

Health Sciences Centre, Winnipeg

L8S1A4

NOT_YET_RECRUITING

Hamilton Health Sciences, Hamilton

M5B1W8

RECRUITING

St. Michael's Hospital, Toronto

M5G2C4

RECRUITING

Toronto General Hospital, Toronto

H3T1C5

RECRUITING

Centre Hospitalier Universitaire Sainte-Justine, Montreal

H4A3J1

NOT_YET_RECRUITING

McGill University Health Centre, Montreal

G1V4G2

RECRUITING

Centre Hospitalier de l'Université Laval, Québec

S4P0W5

NOT_YET_RECRUITING

Regina General Hospital, Regina

All Listed Sponsors
lead

University of British Columbia

OTHER